PRESS RELEASE published on 08/27/2025 at 07:00, 1 year 1 month ago BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis. The designation provides key incentives for addressing drug resistance in TB treatment BioVersys Tuberculosis Alpibectir EMA Orphan Designation Ethionamide
BRIEF published on 07/02/2025 at 07:05, 1 year 3 months ago BioVersys and Shionogi Collaborate on NTM Clinical Candidate Global Commercialization BioVersys Collaboration Shionogi Partnership NTM Clinical Candidate Ansamycin Platform
BRIEF published on 07/02/2025 at 07:05, 1 year 3 months ago BioVersys et Shionogi collaborent sur le candidat clinique NTM Commercialisation Mondiale Collaboration BioVersys Partenariat Shionogi Candidat Clinique NTM Plateforme Ansamycine
PRESS RELEASE published on 07/02/2025 at 07:00, 1 year 3 months ago BIOVERSYS AND SHIONOGI ENTER INTO GLOBAL RESEARCH COLLABORATION FOR BROAD-SPECTRUM NON-TUBERCULOUS MYCOBACTERIA (NTM) CLINICAL CANDIDATE BioVersys and Shionogi enter global research collaboration for NTM clinical candidate. BioVersys grants Shionogi license option for leads from BV500 program Shionogi BioVersys Global Research Collaboration NTM Clinical Candidate
BRIEF published on 06/30/2025 at 07:05, 1 year 3 months ago BioVersys AG Annual General Meeting Yields Positive Outcomes Financial Statements Strategic Initiatives Board Elections BioVersys AGM Capital Amendment
BRIEF published on 06/30/2025 at 07:05, 1 year 3 months ago L'assemblée générale annuelle de BioVersys AG donne des résultats positifs États Financiers Élections Du Conseil D'administration Initiatives Stratégiques Assemblée Générale Annuelle De BioVersys Amendement Capital
PRESS RELEASE published on 06/30/2025 at 07:00, 1 year 3 months ago BIOVERSYS ANNOUNCES RESULTS FROM its ANNUAL GENERAL MEETING OF SHAREHOLDERS BioVersys AG announces results from its Annual General Meeting of Shareholders, including re-election of Board Members and amendment to capital range for strategic initiatives Annual General Meeting Shareholders Board Members BioVersys AG Capital Range
BRIEF published on 06/03/2025 at 07:05, 1 year 4 months ago BioVersys Announces 2025 Annual General Meeting of Shareholders Capital Increase Board Elections Shareholders Meeting 2025 AGM BioVersys AG
BRIEF published on 06/03/2025 at 07:05, 1 year 4 months ago BioVersys annonce l'assemblée générale annuelle des actionnaires de 2025 Augmentation De Capital Élections Du Conseil D'administration Assemblée Générale Des Actionnaires Assemblée Générale Annuelle 2025 BioVersys AG
PRESS RELEASE published on 06/03/2025 at 07:00, 1 year 4 months ago BioVersys publishes Invitation to its ANNUAL GENERAL MEETING OF SHAREHOLDERS 2025 BioVersys AG publishes Invitation to its Annual General Meeting of Shareholders 2025, including agenda with items such as annual report, elections, compensation approval, and capital range amendment Annual General Meeting Shareholders Biopharmaceutical AGM 2025 BioVersys AG
Published on 10/17/2026 at 03:20, 1 day 9 hours ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 1 day 9 hours ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 1 day 13 hours ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 1 day 13 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 1 day 14 hours ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/17/2026 at 18:00, 19 hours ago Baader Bank announces extended trading hours 23 hours a day starting Q1/2027
Published on 10/17/2026 at 13:05, 23 hours 55 minutes ago Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 1 day ago AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 1 day 16 hours ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 1 day 17 hours ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:54, 1 day 17 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 1 day 18 hours ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 1 day 18 hours ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
Published on 10/16/2026 at 18:00, 1 day 19 hours ago KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026